Navigating the Longitudinal HIV Market

The HIV therapeutic area has evolved from acute care to long-term care. B2B stakeholders, such as pharmaceutical teams and public health agencies, need accurate data for lifecycle management and policy development. The Henne Group (THG) offers essential intelligence to navigate this complex market, focusing on the needs of People Living with HIV (PLHIV).

Why the HIV Market Demands Nuanced Intelligence

In a competitive landscape dominated by high-efficacy oral regimens and the emergence of long-acting injectables, success hinges on understanding the friction points in the patient journey. THG specializes in identifying the drivers behind therapeutic shifts and long-term treatment persistence.

​

Our core areas of B2B expertise include:

​

• Therapeutic Switching Dynamics: Identifying the clinical and lifestyle variables that prompt transitions between drug classes, particularly the move toward INSTI-based regimens and long-acting agents.

• Comorbidity & Aging Populations: Providing longitudinal data on the management of age-related conditions and polypharmacy in the aging HIV population.

• Market Access & Payer Alignment: Analyzing how institutional frameworks and reimbursement structures impact the availability and uptake of innovative therapies.

• Implementation Science: Researching the logistical and workflow requirements for clinics transitioning to next-generation delivery systems.

High-Fidelity Recruitment of Segmented Populations

The primary challenge in HIV market research is the recruitment of highly segmented or hard-to-reach populations. THG utilizes a rigorous, data-driven approach to identify and engage specific cohorts, ensuring that your research is representative of the actual market diversity.

​

• Segmented Insights: Deep-dive analysis into ethnic minorities, LGBTQ+ communities, and low-income demographics.

• Rapid Fieldwork: Leveraging our established panel and specialized call center to decrease the time-to-insight for time-sensitive launches.

• Empirical Precision: Moving beyond surface-level sentiment to capture actionable data on patient persistence and physician prescribing behavior.

Operationalizing Data for Commercial and Policy Success

THG simplifies the layered variables of the HIV market into actionable intelligence. We provide the clarity required to build efficient value chains, from early-stage R&D through to post-market surveillance. By focusing on the empirical realities of PLHIV, we help our partners foster an environment conducive to both institutional growth and individual health autonomy.

​

Our methodology ensures that data is never static. We track the feedback loops between policy shifts and market response, providing your organization with the strategic foresight to remain competitive in a non-linear environment.

​

B2B Research Services

​

Quantitative Surveys: Large-scale data collection for market sizing and trend tracking.

Qualitative In-Depth Interviews (IDIs): Uncovering the "why" behind therapy switches and treatment pauses.

Stakeholder Mapping: Aligning the goals of providers, patients, and payers to ensure market penetration.

Longitudinal Tracking: Monitoring patient outcomes and satisfaction over multi-year cycles.